Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Common drug review"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Search alternatives
:
common drug »
common due
Showing
1
-
20
of
790
Search:
'"Common drug review"'
,
query time: 0.09s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
2
CDEC final recommendation: Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
3
CDEC final recommendation: Tiotropium bromide (Spiriva respimat -- Boehringer Ingelheim Canada Ltd.) : indication : chronic obstructive pulmonary disease
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
4
Riociguat (Adempas) : management of inoperable chronic thromboembolic pulmonary hypertension
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
5
CADTH Canadian Drug Expert Committee final recommendation: Emtricitabine / tenofovir alafenamide (Descovy -- Gilead Sciences Canada, Inc.) indication : HIV-1 infection
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
6
CADTH Canadian Drug Expert Committee final recommendation: Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) indication : type 2 diabetes
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
7
CADTH Canadian Drug Expert Committee final recommendation: Tiotropium/Olodaterol (Inspiolto Respimat - Boehringer Ingelheim Canada Ltd.) indication : chronic obstructive pulmonary...
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
8
CADTH Canadian Drug Expert Committee final recommendation: Canagliflozin and metformin hydrochloride (Invokamet -- Janssen Inc.) : type 2 diabetes mellitus
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
9
Glycerol phenylbutyrate (Ravicti)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
10
Propranolol hydrochloride (Hemangiol)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
11
Ledipasvir/Sofosbuvir (Harvoni) : for the treatment of chronic hepatitis C virus (CHC) G1 infection in adults
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
12
Elosulfase alfa (Vimizim)
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
13
Lomitapide (Juxtapid)
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
14
Fentanyl (Fentora)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
15
Entyvio (Vedolizumab)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
16
Fluticasone furoate/Vilanterol (Breo ellipta)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
17
Ivacaftor (Kalydeco) 150 mg tablet : for treatment of cystic fibrosis with G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, S549R, or G970R mutation
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
18
Sofosbuvir (Sovaldi) : sofosbuvir is indicated for the treatment of chronic hepatitis C virus (CHC) infection in adult patients with compensated liver disease, including cirrhosis
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
19
Canakinumab (Ilaris)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
Read Now
20
CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug
review
...
”
1
2
3
4
5
6
7
8
9
10
11
Back
Narrow Search
Year of Publication
From:
To:
Classification
610 - Medicine & health
581
330 - Economics
256
140 - Specific philosophical schools
83
700 - The arts; fine & decorative arts
76
580 - Plants (Botany)
11
380 - Commerce, communications & transportation
7
more ...
615 - Pharmacology & therapeutics
4
see all ...
less ...
Language
English
790
Collection
National Center for Biotechnology Information
790
Author
Canadian Agency for Drugs and Technologies in Health
729
CADTH Canadian Drug Expert Committee
210
Canadian Diabetes Association
4
Kidney Foundation of Canada
2
Multiple Sclerosis Society of Canada
2
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?lookfor=%22Common+drug+review%22&type=Series
Send by Email
×
Loading...